Why Immunity Markers May Predict Esophageal Cancer Recurrence
Scientists are exploring whether certain immunity signals in the body, known as biomarkers, can forecast the comeback of esophageal squamous cell carcinoma (ESCC) within three years. This type of cancer often returns after patients undergo a mix of treatments including immunotherapy and chemotherapy